1-3 of 3
Jim Vadolas
Close
Sort by
Journal Articles

SLN124, a Galnac-siRNA Conjugate Targeting TMPRSS6, for the Treatment of Iron Overload and Ineffective Erythropoiesis Such As in Beta-Thalassemia

Sandro Altamura, PhD, Sandro Altamura, PhD, Martina U. Muckenthaler, PhD, Sibylle Dames, MSc, Christian Frauendorf, PhD, Steffen Schubert, PhD, Manuela Aleku, MSc, Jim Vadolas, PhD, George Grigoriadis, MBBS PhD FRACP FRCPA, Ulrich Zügel, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2340.
https://doi.org/10.1182/blood-2018-99-110163
Published: 2018
Journal Articles

Reduced PU.1 expression underlies aberrant neutrophil maturation and function in β-thalassemia mice and patients

Panjaree Siwaponanan, Jurre Ynze Siegers, Razi Ghazali, Thian Ng, Bradley McColl, Garrett Zhen-Wei Ng, Philip Sutton, Nancy Wang, Isabelle Ooi, Chayada Thiengtavor, Suthat Fucharoen, Pornthip Chaichompoo, Saovaros Svasti, Odilia Wijburg, Jim Vadolas
Journal: Blood
Blood (2017) 129 (23): 3087–3099.
https://doi.org/10.1182/blood-2016-07-730135
Published: 2017
Includes: Supplemental data
Journal Articles

Development of sensitive fluorescent assays for embryonic and fetal hemoglobin inducers using the human β-globin locus in erythropoietic cells

Jim Vadolas, Hady Wardan, Michael Orford, Lucille Voullaire, Faten Zaibak, Robert Williamson, Panayiotis A. Ioannou
Journal: Blood
Blood (2002) 100 (12): 4209–4216.
https://doi.org/10.1182/blood-2001-12-0365
Published: 2002